Thermo Fisher Scientific Inc. TMO NYSE

Thermo Fisher Scientific Inc. (TMO) reported total assets of $110.34B and total liabilities of $56.81B for quarter ending 2025-12-31, resulting in total equity of $53.54B.

The company held $10.11B in cash and short-term investments. Total debt stood at $40.86B, with net debt of $31B. The Debt-to-Equity (D/E) ratio was 0.76 (moderate).

Current ratio is 1.89, indicating strong short-term liquidity. Interest coverage is 6.3x (adequate).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (61/100) — Total assets $110.34B and equity $53.54B support the company's competitive scale
• VALUE (36/100) — Debt-to-Equity 0.76 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 63/100 with 3/7 criteria passed.